News
New Data Shows Just How Powerful the Next Weight-Loss Drugs May Be
Some new medications in development are also trying to solve for a persistent side effect of existing drugs: Patients who lose fat also tend to lose muscle. This can be particularly dangerous for older adults because it makes them more likely to fall and can worsen osteoporosis.
16hon MSN
As the markets for weight-loss drugs develop, pharma companies are having to adapt in search of the next big thing.
A monthly weight loss drug from Amgen helped people lose about 20% of their body weight, according to the results of a phase ...
Alternatives to weekly injections of weight-loss drugs may be on the way. A monthly dose of a new drug called MariTide helped ...
Ozempic is an FDA-approved medication for people with type 2 diabetes. It’s often prescribed off-label for weight loss — that ...
A new study found that weight-loss medications like Ozempic and Mounjaro are not as effective in a “real-world” setting ...
Novo Nordisk's U.S.-listed shares fell more than 5% Monday after the drugmaker revealed the latest results for a new weight-loss treatment.
Patients who took a lower dose lost more weight on average. Read more at straitstimes.com. Read more at straitstimes.com.
Participants in trial of amycretin injectable obesity drug lost an average of 24% of their body weight on highest dose ...
Amgen shares fell sharply on Monday afternoon after the company released results from a weight-loss trial that showed that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback